6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: XTL BIOPHARMACEUTICALS LTD
Filed: May 15, 2018
Period of Report: May 15, 2018
Accession Number: 0001213900-18-006233

View Document ↗ View on SEC.gov ↗